The decline in antioxidant enzyme activity noted in cancer may be ascribed to various processes, including particular genetic variants of SOD and catalase [25], tumor-specific adaptations [26], and the effects of chemotherapy [27]. The gene discussed is SOD1; the disease is neoplasm.